News & Analysis on Clinical Trial Services & Contract Research And Development
Dendreon has finished the construction of its New Jersey manufacturing facility which it will use to produce its investigational active cellular immunotherapy for advanced prostate cancer, hoping to be the first to bring it to patients.
Spurred on by the frustration of drug manufacturers, governors from four US states have petitioned the US Food and Drug Administration (FDA) for clarity in their requirements for the production of generic versions of insulin and human growth hormone...
Pharma firms may soon have the chance to use US prisoners in clinical drug trials after a new report by a panel of medical advisers at the Institute of Medicine recommended government laws against the practice be loosened.
Canada's Allied Research International (ARI) has expanded its Phase I testing capabilities in response to the continued need for extra capacity in this area.
Albany Molecular Research (AMRI) has announced a multi-year drug substance manufacturing agreement with New River Pharmaceuticals, as its attention deficit hyperactivity disorder (ADHD) medicine looks set to hit the market.
Europe's largest sleep clinic has opened in the UK, offering a new option for pharmaceutical firms wishing to conduct clinical testing in this area.
Nexcelom Bioscience, a provider of instruments for cell-based assays, has just launched a new cell counter to make the cell counting process quicker and easier.
Ciphergen Biosystems has agreed to sell its proteomics instrument business to life science research firm Bio-Rad Laboratories for $20m (€15.6m).